London Daily

Focus on the big picture.
Monday, Jul 21, 2025

Moderna empezó la fase tres del ensayo de su  vacuna contra la Covid-19

Moderna enters phase 3 clinical trial of its Covid-19 vaccine

The first major study of a Covid-19 vaccine in the United States began this Monday morning with the administration of one dose to a single patient in Savannah, Georgia, the first inoculation for the Moderna and the National Institutes of Health (NIH) trial, which will evaluate the safety and efficacy of the vaccine in 30,000 people.
The Moderna vaccine, backed by $955 million in government funding, will be tested at 89 sites in the United States.

It uses messenger RNA, a synthetic form of the virus's genetic material designed to propel the body's immune system into an attack mode.

If the trial is successful, the company would produce 500 million doses of its vaccine in 2021, Moderna CEO Stéphane Bancel said in a conference call with government officials.

The first results of the Moderna trial could be available in November or December, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told the conference.

But he indicated that it is "conceivable" that the results could be ready as early as October, if the trial gets ready very quickly in places with a large number of cases.

The trial aims to show that the vaccine is at least 60% effective in preventing covid-19, Fauci said.

Francis Collins, director of the NIH, pointed out that it is "essential" to ensure that trial participants come from diverse backgrounds.

The NIH will weekly track the diversity of the trial to make sure it attracts patients representative of those who have been most affected by the virus in the United States, he said.

We're actually going to rely on that sense of volunteering from people from all corners of society, Collins said at the conference.

Collins also noted that a special panel at the National Academy of Medicine, a private nonprofit organization of doctors and researchers, will advise the government on the difficult decision of who could receive the vaccine first.

Collins said that at least three other phase 3 trials follow closely behind.

The following phase 3 trials will be conducted with vaccines from the University of Oxford, Johnson & Johnson and Novavax Inc., which work within the government's 'Warp Speed' initiative. Furthermore, an upcoming vaccine trial by Pfizer Inc. and BioNTech SE is also approaching a final phase study.

J&J launched its phase 1 clinical trials in the United States on Monday, and it will begin in Belgium on Wednesday, according to the company.

Modern, based in Cambridge, Massachusetts, rose as much as 11% on Monday after announcing Sunday that it will receive $472 million in a second round of funding from the United States for its final phase trial. Shares rose 7.6% in New York at 11:58 am.

The Moderna vaccine, developed in conjunction with the NIH, is one of more than 160 in development to prevent the spread of the disease, and the World Health Organization estimates that about 25 different inoculations are currently in human trial phase.

Government support for the vaccine increases our confidence in its success, BMO analyst George Farmer wrote in a note to clients. Goldman analysts led by Salveen Richter rated Moderna as one of the "most likely labs" to bring a vaccine to market, possibly before the end of the year.
Newsletter

Related Articles

0:00
0:00
Close
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
×